SCHEMBL9949136

SCHEMBL9949136

CC(C)(C)c1ccccc1OP(=O)(Cl)Oc1ccccc1C(C)(C)C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.42
ATM Q13315 1/20 0.42
NPSR1 Q6W5P4 2/20 0.40
NAMPT P43490 1/20 0.40
ALDH1A1 P00352 5/20 0.40
KDM4E B2RXH2 3/20 0.40
GAA P10253 1/20 0.40
RXRA P19793 1/20 0.40
RXRB P28702 1/20 0.40
RXRG P48443 1/20 0.40
CYP1A2 P05177 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C19 P33261 1/20 0.38
HSD17B10 Q99714 1/20 0.38
BCHE P06276 1/20 0.38
TSHR P16473 1/20 0.38
ALOX15 P16050 1/20 0.37
LMNA P02545 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
NISCH Q9Y2I1 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11508414 0.89 TDP1 (0.42) TDP1ATMNPSR1NAMPTALDH1A1
SCHEMBL9949532 0.85 TDP1 (0.44) TDP1ATMNPSR1NAMPTALDH1A1
SCHEMBL190944 0.84 TDP1 (0.45) TDP1ATMNPSR1NAMPTALDH1A1
SCHEMBL29405225 0.84 TDP1 (0.45) TDP1ATMNPSR1NAMPTALDH1A1
SCHEMBL5851967 0.82 LMNA (0.37) ALDH1A1KDM4EHSD17B10LMNASMN1; SMN2
SCHEMBL29885636 0.81 INPPL1 (0.52) TDP1ATMNPSR1NAMPTALDH1A1
SCHEMBL29258964 0.81 TDP1 (0.42) TDP1ATMNPSR1NAMPTALDH1A1
SCHEMBL29462669 0.81 TDP1 (0.46) TDP1ATMNPSR1NAMPTALDH1A1
SCHEMBL284461 0.81 INPPL1 (0.52) TDP1ATMNPSR1NAMPTALDH1A1
SCHEMBL818786 0.81 TDP1 (0.46) TDP1ATMNPSR1NAMPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8410203-B2 Phosphorus compound, method of preparing the same and flame retardant thermoplastic resin composition including the same CHEIL INDUSTRIES INC. (KR) 2013-04-02 US disclosed
US-20120165444-A1 Novel Phosphorus Compound, Method of Preparing the Same and Flame Retardant Thermoplastic Resin Composition Including the Same CHEIL INDUSTRIES INC. (KR) 2012-06-28 US disclosed
EP-2468814-A1 Novel Phosphorus Compound, Method of Preparing the Same and Flame Retardant Thermoplastic Resin Composition Including the Same Cheil Industries Inc. (KR) 2012-06-27 EP disclosed
US-4918056-A ANTITUMOR AGENTS HEALTH RESEARCH, INC. (ROSWELL PARK DIVISION) (US) 1990-04-17 US disclosed
US-4622392-A ANTICARCINOGENIC AGENTS HEALTH RESEARCH INC. (ROSWELL PARK DIVISION) (US) 1986-11-11 US disclosed
US-4291024-A ANTICANCER AGENTS UNIVERSITY OF RHODE ISLAND 1981-09-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120165444-A1 Novel Phosphorus Compound, Method of Preparing the Same and Flame Retardant Thermoplastic Resin Composition Including the Same RPP30, RER1, TAF11 TDP1 1726/4885ATM 2954/4885NPSR1 1981/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.